gigagen.comCrawled Nov 14, 2026
SAN FRANCISCO, CA - GigaGen has invented a novel microfluidic chip geometry for water-in-oil microdroplet merging. The technology is particularly useful for
GigaGen Inc., a biopharmaceutical company developing novel antibody therapies, today announced the disclosure of 17 immuno-oncology targets the company is
Therapies for early and late treatment and passive immunization of COVID-19 are needed and can be developed using antibodies from recovered patients.
“Scrappy.” That’s a one-word summation of GigaGen’s approach to both the business and science of biotech.
David S. Johnson, PhD, MBA, Chief Executive Officer and Co-Founder, GigaGen, speaks to SCRIP about the company's pipeline and business strategy.
Listen to Moira Gunn's interview with Dave Johnson, PhD, CEO of GigaGen on "Creating a Synthetic Immune System" on Biotech Nation Radio.
SOUTH SAN FRANCISCO, May 25, 2021 (GLOBE NEWSWIRE) -- GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases,
SOUTH SAN FRANCISCO, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious
Dr. Adler has more than a decade of research and laboratory management experience, including deep expertise in antibody sequencing. At GigaGen, he leads laboratory research operations and is responsible for the development of GigaGen’s product pipeline in oncology and immune deficiency.
GigaGen hired a biotech executive with experience in antibody drug development and commercialization, previously at Exelixis.
Senior Director, Technology
The scientist has expertise in immunology, genomics, and CAR T-cell research, with experience in genome-editing and high-throughput biology.
GigaGen’s technology captures complete immune repertoires as functional antibody libraries for antibody drug discovery.
Gigagen Inc. is committed to providing a fully accessible website experience for all users of all abilities, including those who rely on assistive
Last updated May 31, 2022
